The startup develops a lightweight, low-powered patch-type electrocardiograph that enables healthcare professionals to monitor heart activity in real-time. This technology allows for early detection of cardiac issues while minimizing resource consumption, enhancing diagnostic capabilities in clinical settings.
Funding
$8.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Continuous monitoring of a patient's heart activity often requires cumbersome equipment and frequent electrode replacements, leading to patient discomfort and inconvenience. Traditional Holter monitors can be difficult to wear during daily activities, such as showering, and may not capture intermittent arrhythmias due to limited monitoring duration.
Solution
ATsens offers AT-Patch, a lightweight, patch-type electrocardiograph (ECG) device designed for long-term continuous heart monitoring. The AT-Patch is a slim, compact, and waterproof device that adheres to the patient's chest, recording high-quality ECG signals for up to 14 days without requiring charging or electrode replacement. Data collected by the AT-Patch is transmitted to the AT-Report software, which utilizes a proprietary algorithm to analyze ECG data, facilitating faster and more accurate diagnoses. The AT-Heart solution also includes the AT-Note mobile application, which allows patients to view real-time ECG data and record symptoms for correlation with recorded cardiac events.
Target Audience
The primary target audience includes healthcare professionals, such as cardiologists and general practitioners, requiring long-term ECG monitoring solutions for arrhythmia detection, as well as patients needing convenient and comfortable cardiac monitoring.
Features
- Patch-type ECG device for continuous monitoring up to 14 days
- High-performance sensing technology for clear and accurate ECG signal recording with minimal noise
- Slim, compact (8.3mm thick), and lightweight (under 13g) design for patient comfort
- IP57-rated for dust and water resistance, allowing patients to shower while wearing the device
- AT-Note mobile application for real-time ECG viewing and symptom logging via Bluetooth
- AT-Report software with proprietary algorithm for precise ECG data analysis and reporting